Catalog Number 362780 |
Device Problem
Device Ingredient or Reagent Problem (2910)
|
Patient Problem
No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 06/09/2023 |
Event Type
malfunction
|
Event Description
|
It was reported when using the bd vacutainer® cpt¿ mononuclear cell preparation tube gel did not separate after centrifugation.This event occurred three times.The following information was provided by the initial reporter.The customer stated: "customer received 3 more samples this week that did not separate.Related with (b)(4).
|
|
Manufacturer Narrative
|
H.3.A device evaluation is anticipated, but has not yet begun.Upon completion of the investigation, a supplemental report will be filed.B.3.Date of event: unknown.The date received by manufacturer has been used for this field.
|
|
Event Description
|
It was reported when using the bd vacutainer® cpt¿ mononuclear cell preparation tube gel did not separate after centrifugation.This event occurred three times.The following information was provided by the initial reporter.The customer stated: "customer received (b)(4) more samples this week that did not separate.Related with (b)(4).
|
|
Manufacturer Narrative
|
H.6 investigation summary.Bd had not received samples, but 2 photos were provided for investigation.The photos were reviewed and the indicated failure mode for poor barrier separation was observed.Additionally, retention samples from bd inventory were visually inspected with no issues observed.Complaints for sample quality are under statistical control for the month of (b)(6) 2023.At this time, further testing is not indicated.Based on a review of the device history record for the incident lot, all product specifications and requirements for lot release were met.There were no related quality issues during manufacturing of the product.This complaint has been confirmed for poor barrier separation based on the photos provided.Bd was not able to identify a root cause for the indicated failure mode.Complaints received for this device and reported condition will continue to be tracked and trended.Our business team regularly reviews the collected data for identification of emerging trends.Bd quality will continue to monitor sample quality complaints.
|
|
Search Alerts/Recalls
|